Guardant Health, Inc. (GH)
USD 46.85
(-4.13%)
USD 46.85
(-4.13%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -564.72 Million USD | -3.33% |
| 2022 | -544.37 Million USD | -32.45% |
| 2021 | -411 Million USD | -61.21% |
| 2020 | -254.95 Million USD | -209.51% |
| 2019 | -82.37 Million USD | 11.37% |
| 2018 | -92.94 Million USD | -21.32% |
| 2017 | -76.61 Million USD | -74.73% |
| 2016 | -43.84 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -100.61 Million USD | -0.94% |
| 2024 Q1 | -99.68 Million USD | 49.53% |
| 2023 Q3 | -113.54 Million USD | 5.08% |
| 2023 FY | -562.51 Million USD | -3.33% |
| 2023 Q2 | -119.61 Million USD | 10.77% |
| 2023 Q1 | -134.05 Million USD | 8.26% |
| 2023 Q4 | -197.51 Million USD | -73.95% |
| 2022 Q1 | -123.33 Million USD | -25.59% |
| 2022 FY | -544.37 Million USD | -32.45% |
| 2022 Q4 | -146.11 Million USD | -1.05% |
| 2022 Q3 | -144.6 Million USD | -10.96% |
| 2022 Q2 | -130.32 Million USD | -5.66% |
| 2021 FY | -411 Million USD | -61.21% |
| 2021 Q4 | -98.2 Million USD | 8.46% |
| 2021 Q3 | -107.28 Million USD | -9.88% |
| 2021 Q2 | -97.64 Million USD | 9.48% |
| 2021 Q1 | -107.86 Million USD | -18.31% |
| 2020 Q4 | -91.16 Million USD | -22.78% |
| 2020 Q3 | -74.25 Million USD | -35.94% |
| 2020 Q2 | -54.62 Million USD | -56.45% |
| 2020 Q1 | -34.91 Million USD | -34.47% |
| 2020 FY | -254.95 Million USD | -209.51% |
| 2019 Q1 | -23.66 Million USD | 13.59% |
| 2019 Q4 | -25.96 Million USD | -48.55% |
| 2019 Q3 | -17.47 Million USD | -14.47% |
| 2019 FY | -82.37 Million USD | 11.37% |
| 2019 Q2 | -15.26 Million USD | 35.48% |
| 2018 Q4 | -27.38 Million USD | -13.15% |
| 2018 Q2 | -22.7 Million USD | -21.75% |
| 2018 Q1 | -18.64 Million USD | -19.4% |
| 2018 FY | -92.94 Million USD | -21.32% |
| 2018 Q3 | -24.2 Million USD | -6.62% |
| 2017 Q1 | -16.15 Million USD | 0.0% |
| 2017 FY | -76.61 Million USD | -74.73% |
| 2017 Q3 | -28.67 Million USD | -65.42% |
| 2017 Q2 | -17.33 Million USD | -7.29% |
| 2017 Q4 | -15.61 Million USD | 45.54% |
| 2016 FY | -43.84 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -480.056% |
| Biodesix, Inc. | -41.34 Million USD | -1265.984% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -6982.765% |
| Castle Biosciences, Inc. | -67.97 Million USD | -730.759% |
| DarioHealth Corp. | -56.18 Million USD | -905.045% |
| Exact Sciences Corporation | -215.01 Million USD | -162.648% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 151.473% |
| Illumina, Inc. | -1.06 Billion USD | 47.173% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -5391.738% |
| iSpecimen Inc. | -11.16 Million USD | -4956.024% |
| Standard BioTools Inc. | -76.6 Million USD | -637.239% |
| 23andMe Holding Co. | -321.35 Million USD | -75.732% |
| Medpace Holdings, Inc. | 336.82 Million USD | 267.661% |
| NeoGenomics, Inc. | -107.73 Million USD | -424.175% |
| Inotiv, Inc. | -81.46 Million USD | -593.254% |
| Psychemedics Corporation | -2.92 Million USD | -19233.276% |
| Prenetics Global Limited | -52.51 Million USD | -975.389% |
| Precipio, Inc. | -7.62 Million USD | -7311.089% |
| RadNet, Inc. | 98.69 Million USD | 672.181% |
| Sotera Health Company | 276.69 Million USD | 304.099% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -12894.133% |
| Exagen Inc. | -22.83 Million USD | -2372.851% |
| Natera, Inc. | -446.24 Million USD | -26.55% |
| Aspira Women's Health Inc. | -18.85 Million USD | -2895.571% |
| Neogen Corporation | 58.66 Million USD | 1062.66% |
| Myriad Genetics, Inc. | -123.7 Million USD | -356.528% |
| ICON Public Limited Company | 956.15 Million USD | 159.062% |
| Bionano Genomics, Inc. | -215.24 Million USD | -162.364% |
| CareDx, Inc | -101.9 Million USD | -454.195% |
| Check-Cap Ltd. | -19.28 Million USD | -2828.009% |
| Twist Bioscience Corporation | -220.83 Million USD | -155.727% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -21673.89% |
| Fulgent Genetics, Inc. | -72.69 Million USD | -676.842% |
| Sera Prognostics, Inc. | -39.82 Million USD | -1318.159% |
| OPKO Health, Inc. | -157.02 Million USD | -259.649% |
| Personalis, Inc. | -109.93 Million USD | -413.685% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -5055.757% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -12894.133% |
| MDxHealth SA | -27.32 Million USD | -1966.546% |
| Prenetics Global Limited | -52.51 Million USD | -975.389% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -5267.733% |
| Mainz Biomed B.V. | -26.64 Million USD | -2019.466% |
| Trinity Biotech plc | -27.04 Million USD | -1988.094% |
| Neuronetics, Inc. | -30.55 Million USD | -1748.285% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -6982.765% |